Evaluation of the Ebola Vaccine's Acceptance Among Sub-Saharan African Communities: A Systematic Review and Meta-Analysis - Summary - MDSpire

Evaluation of the Ebola Vaccine's Acceptance Among Sub-Saharan African Communities: A Systematic Review and Meta-Analysis

  • By

  • Beni Matangi

  • Placide Matondo

  • Brandon Kayembe

  • Axel Okolo

  • Dieudonné Tawaba

  • Amede Kinuka

  • Donat Mangala

  • Ossam Odio

  • Nadine Mayasi

  • Tuna Lukiana

  • Madone Mandina

  • Taylor Pindi

  • Murielle Longokolo

  • Marcel Mbula

  • Hippolyte Situakibanza

  • Ben Bepouka

  • February 6, 2026

  • 0 min

Share

Objective:

To estimate the overall level of acceptability of the Ebola vaccine and identify its determinants among populations in sub-Saharan Africa, highlighting its importance for public health.

Key Findings:
  • Vaccine acceptability rates vary significantly across sub-Saharan Africa, influenced by sociodemographic factors, trust in health authorities, and perceived risk, with implications for public health interventions.
  • Reported acceptability rates range from 38% to 73%, with misinformation and distrust contributing to lower acceptance.
  • The WHO's '3Cs' model (Confidence, Complacency, Convenience) effectively frames the determinants of vaccine hesitancy.
Interpretation:

Understanding the factors influencing Ebola vaccine acceptance is crucial for designing effective public health interventions to improve vaccination coverage and epidemic preparedness in sub-Saharan Africa.

Limitations:
  • Variability in study designs and methodologies may affect the comparability of findings.
  • Exclusion of non-English and non-French studies may limit the comprehensiveness of the review, and potential biases in the studies reviewed should be considered.
Conclusion:

The study highlights the need for targeted interventions to address vaccine hesitancy and improve acceptance rates in the region, emphasizing the urgency of this issue.

Original Source(s)

Related Content